Kyungpook National University Hospital

Daegu, Korea 41944

0 studies enrolling now · 6 studies all time

What they study most

Alopecia Areata, Crohn's Disease, Rheumatoid Arthritis, Systemic Lupus Erythematosus

Studies at this site

• A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata — Completed
• A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Completed
• Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF-06700841 In Subjects With Moderate To Severe Crohn's Disease — Completed
• A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE) — Stopped early
• A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE-BRAVE II) — Completed
• An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis — Completed